Why Is Larimar Therapeutics Stock Trading Lower On Monday?
Larimar Therapeutics, Inc. (NASDAQ:LRMR) released initial data from the ongoing long-term OLE study evaluating daily ...
sciencex1mon
Patients and scientists join forces to tackle Friedreich's Ataxia
It is a monogenic disease, that is to say, it is caused by a defect in only one gene. Those affected by this disorder have inherited an altered frataxin gene from both parents. The project aims to ...
Business Insider26d
Lexeo Therapeutics’ Promising Gene Therapy Progress and Strong Financial Position Present Attractive Investment Opportunity
The company’s alignment with the FDA on key regulatory endpoints for LX2006, such as a 40% frataxin expression and ... which is an AAVrh10-based gene therapy candidate for the treatment of ...
Business Insider1mon
Lexeo Therapeutics Provides Update on Cardiac Portfolio and Reports Third Quarter 2024 Financial Results
Reached alignment with FDA on key elements of registrational development plan for LX2006, including accelerated approval pathway with left-ventricular mass index (LVMI) and frataxin protein ...